この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Samuel B.に依頼
United States
Biomedical researcher with a background in developmental neurobiology, translational medicine, and cancer biology
プロフィール概要
専門分野
サービス
職務経験
Anatomy & Physiology Editor (Contractor)
CourseHero
2月 2018 - 6月 2018
Editor - Neuroscience Center for Excellence
Cactus Communications
2月 2017 - 7月 2017
学歴
Bachelors - Neuroscience
Skidmore College
9月 2008 - 5月 2012
認定資格
- 認定資格の詳細は未入力です。
出版物
OTHER
Samuel Brook, Moshe Elkabets(2018). Methods to Study the Role of Progranulin in the Tumor Microenvironment . 155--176Springer New York
JOURNAL ARTICLE
Samuel Brook, Aviram Mizrachi, Yosi Shamay, Janki Shah, Joanne Soong, Vinagolu K. Rajasekhar, John L. Humm, John H. Healey, Simon N. Powell, José Baselga, et al.(2017). Tumour-specific {PI}3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma . Nature Communications. 8. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 14292. Springer Nature
Y. Shamay, M. Elkabets, H. Li, J. Shah, S. Brook, F. Wang, K. Adler, E. Baut, M. Scaltriti, P. V. Jena, et al.(2016). P-selectin is a nanotherapeutic delivery target in the tumor microenvironment . Science Translational Medicine. 8. (345). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 345ra87--345ra87. American Association for the Advancement of Science ({AAAS})
Samuel Brook, Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric, Qing Sheng, Raphael A. Pelossof, Ana Oaknin Benzaken, Jordi Rodon, Natasha Morse, Jenny Jiacheng Yan, et al.(2015). {AXL} Mediates Resistance to {PI}3K$\upalpha$ Inhibition by Activating the {EGFR}/{PKC}/{mTOR} Axis in Head and Neck and Esophageal Squamous Cell Carcinomas . Cancer Cell. 27. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 533--546. Elsevier {BV}